Literature DB >> 12529734

Another interaction of the FcR system with IVIG.

James B Bussel1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12529734

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  High-dose immunoglobulin preparations improve survival in a CLP-induced rat model of sepsis.

Authors:  Takahisa Yoshikawa; Hiroya Takeuchi; Koichi Suda; Taku Miyasho; Shingo Yamada; Minoru Okamoto; Yoshio Kawamura; Ikuro Maruyama; Masaki Kitajima; Yuko Kitagawa
Journal:  Langenbecks Arch Surg       Date:  2011-11-25       Impact factor: 3.445

2.  Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia.

Authors:  Feng Jin; Zia R Tayab; Joseph P Balthasar
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

3.  Intravenous immunoglobulin does not increase FcγRIIB expression levels on monocytes in children with immune thrombocytopenia.

Authors:  M Shimomura; S Hasegawa; Y Seki; R Fukano; N Hotta; T Ichiyama
Journal:  Clin Exp Immunol       Date:  2012-07       Impact factor: 4.330

Review 4.  Role of FcγRIIIA (CD16) in IVIg-mediated anti-inflammatory function.

Authors:  Sanae Ben Mkaddem; Meryem Aloulou; Marc Benhamou; Renato C Monteiro
Journal:  J Clin Immunol       Date:  2014-04-13       Impact factor: 8.317

5.  Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.

Authors:  Shohei Ogata; Chisato Shimizu; Alessandra Franco; Ranim Touma; John T Kanegaye; Biswa P Choudhury; Natasha N Naidu; Yutaka Kanda; Long T Hoang; Martin L Hibberd; Adriana H Tremoulet; Ajit Varki; Jane C Burns
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.